Doctor of Medicine (M.D.)
Medicine
Columbia University College of Physicians and Surgeons
2005
Ginette A. Okoye, M.D. is associate dean for Clinical Affairs and professor and chair of dermatology at Howard University College of Medicine. A nationally recognized dermatologist, educator and academic leader, her clinical and research interests focus on hidradenitis suppurativa and advancing health equity in dermatologic care. She has authored more than 100 publications and is editor of The Fundamentals of Ethnic Hair: The Dermatologist’s Perspective.
Okoye earned her bachelor’s degree from Barry University and her medical degree from Columbia University College of Physicians and Surgeons. She completed her dermatology residency at Yale University.
Okoye has received numerous honors from the American Academy of Dermatology, including two Presidential Citations, a Volunteerism Award, the Patient Care Hero Award and the 2023 William James Mentor of the Year Award.
Medicine
Columbia University College of Physicians and Surgeons
2005
Biology
Barry University
2000
Specialty Areas: Skin of Color, Hidradenitis Suppurativa
2010 – 2011. “Improving Acne Keloidalis Nuchae by inducing matrix metalloproteinases in vivo using targeted ultraviolet-B irradiation.” Skin of Color Society Research Award. Total cost: $7500. PI: Ginette A. Hinds, MD
2011 - 2012. "Investigating the role of microbial diversity and biofilm formation in Hidradenitis Suppurativa." Dermatology Foundation Patient Directed Investigation Grant. Total cost: $20,000. PI: Ginette A. Hinds, M.D.
2011 - 2013. (P50 HL107185). “Diagnostic Tests and Immunotherapy of Sarcoidosis Using Mycobacterial Proteins.” National Institutes of Health. Total cost: $300,000. PI: David Moller, M.D. Co-Investigator: Ginette A. Hinds, M.D.
Principal Investigator: 2014 - 2018. “Follicular Regeneration after Wounding in Central Centrifugal Cicatricial Alopecia.” Sponsor: Lutronics, Inc. Total cost: $63,000. PI: Ginette A. Okoye, M.D.
Co-Investigator: 2016 – 2018. “Effect of LY3202626 on Alzheimer’s Disease Progression as Measured by Cerebral 18F-AV-1451 Tau-PET in Mild Alzheimer’s Disease Dementia.” PI: Paul Rosenberg, M.D. Sponsor: Eli Lilly and Company
Co-Investigator: 2016 – 2018. “Study for the Development of Outcome Measures for Hidradenitis Suppurativa.” PI: Joslyn S. Kirby M.D.
Principal Investigator: 2016 – 2018. “Early Molecular Changes in Vitiligo in Response to NBUVB.” Total cost: $60,000. Sponsor: Daavlin
Principal Investigator: 2016 – 2018. “Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids.” Sponsor: Lutronics, Inc.
Co-Principal Investigator: 2020 – 2022. Blaustein grant award: “The impact of pain and sleep on surgical wound healing in hidradenitis suppurativa.” PI: Julie Caffrey, D.O.
Principal Investigator: 2021 – 2024. Comparing Home- Versus Clinic-Based Phototherapy for the Treatment of Psoriasis - The LITE Study (PCORI)
Co-Investigator: 2025 – 2027. A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1). Sponsor: Novartis. PI: Cheri Frey, MD
Awarded by the rotating and visiting medical students at the Johns Hopkins Department of Dermatology "in recognition of the faculty most dedicated to teaching"
Listen: NPR | Meet The Dermatologists Advancing Better Care For Skin Of Color
Listen: The Dermatologist | Dr. Okoye on Treating Psoriasis in Patients with Skin of Color
Listen: PeDRA Pearls | Unraveling HS: Exploring Hidradenitis Suppurativa Research - Episode Three
Listen: American Academy of Dermatology (AAD) Dialogues in Dermatology Podcast | Differentiating CTCL from Atopic Dermatitis and Psoriasis in Skin of Color
Listen: Medscape Hidradenitis Suppurativa Podcast | Episode 1: Joint Pain in Paradise: A Closer Look at Arthritis and HS
Listen: Medscape Hidradenitis Suppurativa Podcast | Episode 2: Joint Pain in Paradise: HS, Microbiomes, and Whole Body Healing
Listen: Medscape Hidradenitis Suppurativa Podcast | Episode 3: Joint Pain in Paradise: Cracking the Code: Insulin Resistance in HS
Listen: Medscape Hidradenitis Suppurativa Podcast | Episode 4: Joint Pain in Paradise: A Surgeon’s Guide to HS
Listen: Medscape Hidradenitis Suppurativa Podcast | Episode 5: Joint Pain in Paradise: Advanced Antibiotic Strategies in HS
Listen: Medscape Hidradenitis Suppurativa Podcast | Episode 6: Joint Pain in Paradise: How Can Ob-Gyn and Derm Partner on HS Care
Read: Dermatology Foundation Newsletter | Just a Really Curious Clinician
Read: HCP Live | Ginette Okoye, MD: Disparities in Care for Patients with Hidradenitis Suppurativa
Read: Practical Dermatology | AAD Honors Dr. Ginette Okoye with National Patient Care Hero Award for COVID-19 Testing Work
Fundamentals of Ethnic Hair: The Dermatologist’s Perspective
Written to address the growing trend of hair loss in ethnic populations, The Fundamentals of Ethnic Hair: A Dermatologist's Perspective elucidates the science of curly hair, demystifies prevailing hair styling trends, and presents practical advice for minimizing the harmful effects of these hair styling practices. Written from a dermatologist's perspective, this textbook seamlessly blends science and practical management. Chapters include physical and chemical properties of the hair, thermal and chemical straightening, extensions, razor bumps and special cultural considerations.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with complex immune dysregulation. While previous studies have reported tertiary lymphoid structures (TLS) and IgA-producing B cells in HS skin lesions, the pathogenic role of IgA autoantibodies remains insufficiently characterized. Here, we demonstrate that lesional skin from patients with HS exhibits elevated expression of IGHA1, IGHA2, and J chain, as confirmed by qPCR, immunofluorescence, and Western blot analyses. Single-cell RNA sequencing identified local plasma cells and B cells as the primary source of IgA.
Background
Academic dermatologists manage a broad array of responsibilities, often extending beyond clinical duties to include education, research, mentorship, and administrative work.
Objective
This study aimed to quantify the scope of paid and unpaid responsibilities among academic dermatologists in the United States and identify disparities based on gender, career stage, and geography.
A better understanding of MF pathogenesis in SOC patients is needed for early identification and effective treatment. To address this need, we designed our study to specifically assess RNA and protein expression in biopsies from SOC patients seen at Howard University. We asked the following question: are there biomarkers or potential treatment targets that we could identify from these patient biopsies? To answer this question, we first used bulk RNA microarray analysis to compare samples in our cohort with previously published biomarkers.
Substantial disparities in access to health care, including to physician specialists, hinder diagnosis, treatment, and outcomes for patients with immunological diseases; thus, more studies are needed to understand and address these disparities. This study aimed to evaluate factors associated with disparities in rheumatology, dermatology, and gastroenterology specialist access for patients with immunological conditions and the consequences of such disparities.
US health care disparities in immunology biologics access: a systematic review
Biologics have substantially improved health outcomes for patients with immunologic conditions. However, not all patients have equitable access to these important medications. Accordingly, we conducted a systematic review to understand US health care disparities in biologics access and associated clinical and economic outcomes, including health care resource use, across immunology (ie, rheumatology, gastroenterology, and dermatology).
Defining hidradenitis suppurativa (HS) subtypes was previously limited by small sample sizes and poor interrater reliability; no study has investigated subtype treatment responses. The objective of this analysis was to characterize HS clusters in adult patients with moderate to severe HS and evaluate secukinumab treatment responses between clusters.
Plenary Lectures:
Visiting Professorships/Named Lectureships:
Recorded live at the SDPA Summer 2025 Conference in Washington, DC, this conversation features Dr. Ginette Okoye following her lecture on hidradenitis suppurativa (HS). She sits down with SDPA Communications Committee Co-Chair Rob Casquejo, PA-C to discuss key clinical insights and practical takeaways for improving HS care.